Latest Regulatory News

Origin Energy reported a robust half-year result for December 2024, with revenue up 10% and profit rising 2%, while accelerating investments in battery storage and renewables.

Treasury Wine Estates has announced a 20-cent per share dividend for the half-year ending December 2024, accompanied by a fully franked component and an active Dividend Reinvestment Plan.

Telix Pharmaceuticals has gained UK MHRA approval for Illuccix, its advanced prostate cancer PET imaging agent, promising to alleviate supply shortages and improve diagnostic accuracy across the UK.

Insurance Australia Group Limited (IAG) has announced a quarterly dividend of AUD 1.5786 per Capital Note, payable on March 17, 2025, with a 60% franking rate reflecting partial tax credits for investors.

IAG reported a 91% surge in net profit after tax to $778 million for 1H25, boosted by favourable weather conditions and a $200 million release from COVID-related provisions. The insurer declared a 12 cents per share interim dividend, underscoring its strong capital position and commitment to customer support amid ongoing economic pressures.

Insurance Australia Group Limited (IAG) has announced an ordinary dividend of AUD 0.12 per share, partially franked at 60%, with key dates set for February and March 2025.

Insurance Australia Group Limited (IAG) reported a 91.2% surge in net profit to $778 million for the half year ended December 2024, driven by robust insurance margins and higher investment income. The company also declared a 12-cent interim dividend, signaling confidence in its financial outlook.

Pioneer Lithium has successfully raised $1.3 million in the first tranche of a $1.62 million placement, earmarked to accelerate its uranium project development. A second tranche awaits shareholder approval, signaling continued momentum for the company’s strategic growth.

Infini Resources Limited has announced a $3.4 million capital raise through a flow-through share offer aimed at advancing exploration at its Portland Creek Uranium Project in Canada. The prospectus highlights significant risks but underscores the company's strategic focus on critical minerals.

Visioneering Technologies Inc. has requested an immediate suspension from ASX trading as it prepares for removal from the official list, raising questions about the company’s future.

Artrya has secured a pivotal three-year commercial contract with Sonic Healthcare Australia to deploy its AI-driven Salix Coronary Anatomy platform across over 125 radiology centres, marking a significant step in commercialising its coronary artery disease diagnostic technology.

Echo IQ has secured a $1.26 million refund under the Australian Government's R&D Tax Incentive, reinforcing its commitment to AI-driven solutions for structural heart disease detection.